SGHT
Sight Sciences, Inc.
Price Chart
Latest Quote
$5.28
+0.27 (+5.39%)
Current Price
| Previous Close | $5.01 |
| Open | $5.12 |
| Day High | $5.33 |
| Day Low | $5.08 |
| Volume | 281,519 |
Stock Information
| Shares Outstanding | 54.41M |
| Total Debt | $41.76M |
| Cash Equivalents | $84.96M |
| Revenue | $79.55M |
| Net Income | $-37.25M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $287.28M |
| EPS (TTM) | $-0.70 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $244.08M |
| Sales | $79.55M |
| Income | $-37.25M |
| Book/sh | $1.00 |
| Cash/sh | $1.56 |
| Employees | 186 |
Financial Ratios
| Quick Ratio | 5.26 |
| Current Ratio | 5.86 |
| Debt/Eq | 77.47 |
Returns & Margins
| ROA | -14.34% |
| ROE | -56.64% |
| Gross Margin | 86.17% |
| Operating Margin | -35.60% |
| Profit Margin | -46.83% |
Ownership
| Insider Ownership | 20.37% |
| Institutional Ownership | 53.95% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -8.00 |
| P/S | 3.61 |
| P/B | 5.29 |
Analyst Data
| Recommendation | none |
| Target Price | $8.54 |
Technical Indicators
| SMA20 | $4.84 |
| SMA50 | $4.58 |
| SMA200 | $5.28 |
| RSI | 59.91 |
| ATR | 0.3199 |
| Shares Float | 35.13M |
| Short Float | 2.26% |
| Short Ratio | 4.28 |
| Volatility | 2.40 |
| Rel Volume | 1.90 |
Performance History
| Week | +10.23% |
| Month | +11.86% |
| Quarter | +47.90% |
| 6 Months | -37.07% |
| YTD | -29.41% |
| Year | +31.02% |
| 3 Years | -39.45% |
| 10 Years | -84.24% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $5.28 | 281,600 |
| 2026-06-17 | $5.01 | 150,000 |
| 2026-06-16 | $5.02 | 238,600 |
| 2026-06-15 | $5.02 | 87,200 |
| 2026-06-12 | $5.13 | 155,400 |
| 2026-06-11 | $4.79 | 85,400 |
| 2026-06-10 | $4.82 | 144,300 |
| 2026-06-09 | $4.85 | 144,100 |
| 2026-06-08 | $4.63 | 82,300 |
| 2026-06-05 | $4.45 | 78,300 |
| 2026-06-04 | $4.60 | 105,400 |
| 2026-06-03 | $4.34 | 192,800 |
| 2026-06-02 | $4.34 | 163,100 |
| 2026-06-01 | $4.54 | 159,700 |
| 2026-05-29 | $4.86 | 141,600 |
| 2026-05-28 | $5.06 | 119,300 |
| 2026-05-27 | $4.87 | 145,900 |
| 2026-05-26 | $4.99 | 181,000 |
| 2026-05-22 | $5.03 | 150,600 |
| 2026-05-21 | $5.14 | 164,200 |
| 2026-05-20 | $4.86 | 162,200 |
| 2026-05-19 | $4.72 | 108,000 |
About Sight Sciences, Inc.
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and OMNI EDGE, an implant-free and minimally invasive glaucoma surgery technology. The company also provides SION, a bladeless and manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork; and TearCare system, a proprietary, interventional, dry eye device designed to melt and facilitate the comprehensive removal of meibomian gland obstructions and restore gland functionality and healthy oil production for adult patients with evaporative dry eye disease due to meibomian gland disease when used in conjunction with manual expression of the meibomian glands for ophthalmologists and optometrists. It serves hospitals, medical centers, and eyecare professionals through sales representatives and distributors. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
đ° Latest News
Discover 3 Promising Penny Stocks With Market Caps Over $20M
Simply Wall St. âĸ 2026-06-09T12:05:26Z
Sight Sciences Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-07T05:12:06Z
Sight Sciences, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-07T00:35:25Z
Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks âĸ 2026-05-06T23:30:05Z
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-06T22:30:07Z
Sight Sciences (SGHT) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-06T22:25:58Z
Fuel Tech Leads The Pack Of 3 Noteworthy Penny Stocks
Simply Wall St. âĸ 2026-04-29T18:05:43Z
Arq And 2 Other Promising Penny Stocks
Simply Wall St. âĸ 2026-03-30T18:05:45Z
Sight Sciences, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-05T13:30:00Z
Sight Sciences Inc (SGHT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ...
GuruFocus.com âĸ 2026-03-05T05:02:10Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $10,697,000 | $11,581,000 | $11,881,000 | $12,361,000 |
| Cost Of Revenue | $10,697,000 | $11,581,000 | $11,881,000 | $12,361,000 |
| Total Revenue | $77,363,000 | $79,866,000 | $81,056,000 | $71,331,000 |
| Operating Revenue | $77,363,000 | $79,866,000 | $81,056,000 | $71,331,000 |
| Expenses | ||||
| Interest Expense | $5,142,000 | $4,662,000 | $5,408,000 | $4,466,000 |
| Total Expenses | $114,462,000 | $130,398,000 | $138,330,000 | $155,285,000 |
| Other Income Expense | $3,825,000 | $3,923,000 | $7,245,000 | $2,225,000 |
| Other Non Operating Income Expenses | $-148,000 | $-32,000 | $-44,000 | $2,225,000 |
| Net Non Operating Interest Income Expense | $-5,142,000 | $-4,662,000 | $-5,408,000 | $-4,466,000 |
| Interest Expense Non Operating | $5,142,000 | $4,662,000 | $5,408,000 | $4,466,000 |
| Operating Expense | $103,765,000 | $118,817,000 | $126,449,000 | $142,924,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-38,426,000 | $-51,507,000 | $-55,547,000 | $-86,242,000 |
| Net Interest Income | $-5,142,000 | $-4,662,000 | $-5,408,000 | $-4,466,000 |
| Normalized Income | $-42,399,000 | $-54,631,450 | $-62,836,000 | $-86,242,000 |
| Net Income From Continuing And Discontinued Operation | $-38,426,000 | $-51,507,000 | $-55,547,000 | $-86,242,000 |
| Total Operating Income As Reported | $-37,099,000 | $-50,532,000 | $-57,274,000 | $-83,954,000 |
| Net Income Common Stockholders | $-38,426,000 | $-51,507,000 | $-55,547,000 | $-86,242,000 |
| Net Income | $-38,426,000 | $-51,507,000 | $-55,547,000 | $-86,242,000 |
| Net Income Including Noncontrolling Interests | $-38,426,000 | $-51,507,000 | $-55,547,000 | $-86,242,000 |
| Net Income Continuous Operations | $-38,426,000 | $-51,507,000 | $-55,547,000 | $-86,242,000 |
| Pretax Income | $-38,416,000 | $-51,271,000 | $-55,437,000 | $-86,195,000 |
| Special Income Charges | $0 | $-1,962,000 | $0 | - |
| Operating Income | $-37,099,000 | $-50,532,000 | $-57,274,000 | $-83,954,000 |
| Gross Profit | $66,666,000 | $68,285,000 | $69,175,000 | $58,970,000 |
| Interest Income | - | - | - | - |
| Interest Income Non Operating | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $-0.74 | $-1.03 | $-1.14 | $-1.80 |
| Basic EPS | $-0.74 | $-1.03 | $-1.14 | $-1.80 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $830,550 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-36,760,000 | $-49,852,000 | $-56,704,000 | $-81,019,000 |
| Total Unusual Items | $3,973,000 | $3,955,000 | $7,289,000 | - |
| Total Unusual Items Excluding Goodwill | $3,973,000 | $3,955,000 | $7,289,000 | - |
| Reconciled Depreciation | $487,000 | $712,000 | $614,000 | $710,000 |
| EBITDA (Bullshit earnings) | $-32,787,000 | $-45,897,000 | $-49,415,000 | $-81,019,000 |
| EBIT | $-33,274,000 | $-46,609,000 | $-50,029,000 | $-81,729,000 |
| Diluted Average Shares | $52,148,543 | $50,134,104 | $48,628,940 | $47,849,058 |
| Basic Average Shares | $52,148,543 | $50,134,104 | $48,628,940 | $47,849,058 |
| Diluted NI Availto Com Stockholders | $-38,426,000 | $-51,507,000 | $-55,547,000 | $-86,242,000 |
| Tax Provision | $10,000 | $236,000 | $110,000 | $47,000 |
| Gain On Sale Of Security | $3,973,000 | $5,917,000 | $7,289,000 | - |
| Research And Development | $14,606,000 | $17,991,000 | $17,556,000 | $22,859,000 |
| Selling General And Administration | $89,159,000 | $100,826,000 | $108,893,000 | $120,065,000 |
| Other Special Charges | - | $1,962,000 | - | - |
Fetched: 2026-06-19
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $63,942,000 | $87,523,000 | $120,215,000 | $160,076,000 |
| Total Assets | $115,300,000 | $142,839,000 | $166,651,000 | $213,073,000 |
| Total Non Current Assets | $2,566,000 | $3,065,000 | $3,780,000 | $3,396,000 |
| Other Non Current Assets | $518,000 | $550,000 | $682,000 | $211,000 |
| Current Assets | $112,734,000 | $139,774,000 | $162,871,000 | $209,677,000 |
| Other Current Assets | $3,257,000 | $2,306,000 | $2,604,000 | $3,415,000 |
| Inventory | $7,767,000 | $6,325,000 | $7,849,000 | $6,114,000 |
| Receivables | $9,745,000 | $10,786,000 | $14,289,000 | $15,148,000 |
| Accounts Receivable | $9,745,000 | $10,786,000 | $14,289,000 | $15,148,000 |
| Allowance For Doubtful Accounts Receivable | $-234,000 | $-689,000 | $-1,186,000 | $-1,024,000 |
| Gross Accounts Receivable | $9,979,000 | $11,475,000 | $15,475,000 | $16,172,000 |
| Cash Cash Equivalents And Short Term Investments | $91,965,000 | $120,357,000 | $138,129,000 | $185,000,000 |
| Cash And Cash Equivalents | $91,965,000 | $120,357,000 | $138,129,000 | $185,000,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $40,775,000 | $40,362,000 | $35,414,000 | $34,981,000 |
| Long Term Debt And Capital Lease Obligation | $40,300,000 | $39,829,000 | $32,622,000 | $33,948,000 |
| Long Term Debt | $40,300,000 | $39,356,000 | $31,708,000 | $33,313,000 |
| Current Debt And Capital Lease Obligation | $475,000 | $533,000 | $2,792,000 | $1,033,000 |
| Current Debt | - | - | $2,219,000 | - |
| Other Current Borrowings | - | - | $2,219,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $51,358,000 | $55,316,000 | $46,436,000 | $52,997,000 |
| Total Non Current Liabilities Net Minority Interest | $40,331,000 | $39,848,000 | $34,184,000 | $35,180,000 |
| Other Non Current Liabilities | $31,000 | $19,000 | $38,000 | $38,000 |
| Current Liabilities | $11,027,000 | $15,468,000 | $12,252,000 | $17,817,000 |
| Payables And Accrued Expenses | $4,478,000 | $5,255,000 | $4,932,000 | $9,430,000 |
| Interest Payable | $357,000 | $344,000 | $375,000 | $348,000 |
| Payables | $1,343,000 | $1,691,000 | $1,731,000 | $2,688,000 |
| Accounts Payable | $1,343,000 | $1,691,000 | $1,731,000 | $2,688,000 |
| Tradeand Other Payables Non Current | - | $0 | $1,524,000 | $1,194,000 |
| Other Current Liabilities | - | - | - | $2,000 |
| Derivative Product Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $63,942,000 | $87,523,000 | $120,215,000 | $160,076,000 |
| Total Equity Gross Minority Interest | $63,942,000 | $87,523,000 | $120,215,000 | $160,076,000 |
| Stockholders Equity | $63,942,000 | $87,523,000 | $120,215,000 | $160,076,000 |
| Retained Earnings | $-384,723,000 | $-346,297,000 | $-294,790,000 | $-239,243,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $53,493,711 | $50,937,999 | $49,131,363 | $48,298,138 |
| Share Issued | $53,493,711 | $50,937,999 | $49,131,363 | $48,298,138 |
| Tangible Book Value | $63,942,000 | $87,523,000 | $120,215,000 | $160,076,000 |
| Invested Capital | $104,242,000 | $126,879,000 | $154,142,000 | $193,389,000 |
| Working Capital | $101,707,000 | $124,306,000 | $150,619,000 | $191,860,000 |
| Capital Lease Obligations | $475,000 | $1,006,000 | $1,487,000 | $1,668,000 |
| Total Capitalization | $104,242,000 | $126,879,000 | $151,923,000 | $193,389,000 |
| Additional Paid In Capital | $448,611,000 | $433,769,000 | $414,956,000 | $399,271,000 |
| Capital Stock | $54,000 | $51,000 | $49,000 | $48,000 |
| Common Stock | $54,000 | $51,000 | $49,000 | $48,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $473,000 | $914,000 | $635,000 |
| Current Capital Lease Obligation | $475,000 | $533,000 | $573,000 | $1,033,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $6,074,000 | $9,680,000 | $4,528,000 | $7,352,000 |
| Current Accrued Expenses | $3,135,000 | $3,564,000 | $3,201,000 | $6,742,000 |
| Net PPE | $2,048,000 | $2,515,000 | $3,098,000 | $3,185,000 |
| Accumulated Depreciation | $-2,401,000 | $-2,106,000 | $-1,627,000 | $-1,434,000 |
| Gross PPE | $4,449,000 | $4,621,000 | $4,725,000 | $4,619,000 |
| Leases | $38,000 | $38,000 | $38,000 | $38,000 |
| Construction In Progress | $1,260,000 | $1,218,000 | $859,000 | $475,000 |
| Other Properties | $2,653,000 | $2,926,000 | $3,468,000 | $3,787,000 |
| Machinery Furniture Equipment | $498,000 | $439,000 | $360,000 | $319,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-300,000 | $-300,000 | $-500,000 | $-100,000 |
| Other Inventories | $67,000 | $25,000 | $49,000 | $14,000 |
| Finished Goods | $6,800,000 | $5,600,000 | $7,300,000 | $5,800,000 |
| Raw Materials | $1,200,000 | $1,000,000 | $1,000,000 | $400,000 |
Fetched: 2026-06-19
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-29,918,000 | $-22,736,000 | $-47,975,000 | $-76,935,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-29,694,000 | $-22,351,000 | $-47,184,000 | $-75,965,000 |
| Cash Flow From Continuing Operating Activities | $-29,694,000 | $-22,351,000 | $-47,184,000 | $-75,965,000 |
| Operating Gains Losses | $15,000 | $1,116,000 | $66,000 | $85,000 |
| Investing Activities | ||||
| Capital Expenditure | $-224,000 | $-385,000 | $-791,000 | $-970,000 |
| Investing Cash Flow | $-224,000 | $-385,000 | $-791,000 | $-970,000 |
| Cash Flow From Continuing Investing Activities | $-224,000 | $-385,000 | $-791,000 | $-970,000 |
| Financing Activities | ||||
| Financing Cash Flow | $1,791,000 | $4,964,000 | $1,104,000 | $1,248,000 |
| Cash Flow From Continuing Financing Activities | $1,791,000 | $4,964,000 | $1,104,000 | $1,248,000 |
| Net Other Financing Charges | $-58,000 | $-261,000 | $-224,000 | - |
| Issuance Of Capital Stock | - | - | - | $0 |
| Net Common Stock Issuance | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $0 | $-35,375,000 | $0 | - |
| Issuance Of Debt | $0 | $39,526,000 | $0 | - |
| Interest Paid Supplemental Data | $4,185,000 | $4,262,000 | $4,267,000 | $3,252,000 |
| End Cash Position | $92,230,000 | $120,357,000 | $138,129,000 | $185,000,000 |
| Beginning Cash Position | $120,357,000 | $138,129,000 | $185,000,000 | $260,687,000 |
| Changes In Cash | $-28,127,000 | $-17,772,000 | $-46,871,000 | $-75,687,000 |
| Proceeds From Stock Option Exercised | $1,849,000 | $1,074,000 | $1,328,000 | $1,248,000 |
| Net Issuance Payments Of Debt | $0 | $4,151,000 | $0 | - |
| Net Long Term Debt Issuance | $0 | $4,151,000 | $0 | - |
| Long Term Debt Payments | $0 | $-35,375,000 | $0 | - |
| Long Term Debt Issuance | $0 | $39,526,000 | $0 | - |
| Net PPE Purchase And Sale | $-224,000 | $-385,000 | $-791,000 | $-970,000 |
| Purchase Of PPE | $-224,000 | $-385,000 | $-791,000 | $-970,000 |
| Change In Working Capital | $-6,395,000 | $9,000,000 | $-9,134,000 | $-5,696,000 |
| Change In Other Current Liabilities | $0 | $-1,563,000 | $330,000 | $353,000 |
| Change In Other Current Assets | $-150,000 | $-51,000 | $-470,000 | $-10,000 |
| Change In Payables And Accrued Expense | $-5,029,000 | $5,140,000 | $-8,311,000 | $3,304,000 |
| Change In Accrued Expense | $-4,681,000 | $4,804,000 | $-7,428,000 | $3,998,000 |
| Change In Payable | $-348,000 | $336,000 | $-883,000 | $-694,000 |
| Change In Account Payable | $-348,000 | $336,000 | $-883,000 | $-694,000 |
| Change In Prepaid Assets | $-686,000 | $299,000 | $812,000 | $751,000 |
| Change In Inventory | $-1,442,000 | $1,630,000 | $-2,156,000 | $-3,253,000 |
| Change In Receivables | $912,000 | $3,545,000 | $661,000 | $-6,841,000 |
| Changes In Account Receivables | $912,000 | $3,545,000 | $661,000 | $-6,841,000 |
| Other Non Cash Items | $1,442,000 | $1,399,000 | $1,620,000 | $1,199,000 |
| Stock Based Compensation | $13,054,000 | $17,077,000 | $14,581,000 | $12,963,000 |
| Provisionand Write Offof Assets | $129,000 | $-148,000 | $616,000 | $1,016,000 |
| Depreciation Amortization Depletion | $487,000 | $712,000 | $614,000 | $710,000 |
| Depreciation And Amortization | $487,000 | $712,000 | $614,000 | $710,000 |
| Gain Loss On Investment Securities | $11,000 | $60,000 | - | - |
| Gain Loss On Sale Of PPE | $4,000 | $23,000 | $66,000 | $85,000 |
| Net Income From Continuing Operations | $-38,426,000 | $-51,507,000 | $-55,547,000 | $-86,242,000 |
| Depreciation | - | - | $614,000 | $710,000 |
| Change In Other Working Capital | - | - | - | $1,364,000 |
Fetched: 2026-06-19